According to G1 Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,30 โฌ. In 2022 the company made an earnings per share (EPS) of -3,07 โฌ an increase over its 2021 EPS that were of -3,22 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,32 โฌ | -56.99% |
2022 | -3,07 โฌ | -4.53% |
2021 | -3,22 โฌ | 34.22% |
2020 | -2,40 โฌ | -19.33% |
2019 | -2,97 โฌ | 26.36% |
2018 | -2,35 โฌ | -10.06% |
2017 | -2,62 โฌ | 68.91% |
2016 | -1,55 โฌ |